James Liebmann, MD; Clark Haskins, MD; Barbara McAneny, MD; Richard Giudice, MD; Douglas Clark, MD; Natalie Marshall, MD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Liebmann J., Haskins C., McAneny B., Giudice R., Clark D., Marshall N.; Chemotherapy in Women with Breast Cancer. Ann Intern Med. 2003;139:867-868. doi: 10.7326/0003-4819-139-10-200311180-00024
Download citation file:
Published: Ann Intern Med. 2003;139(10):867-868.
TO THE EDITOR:
Du and colleagues (1) reported that in New Mexico between 1991 and 1997, only 29% of women with a diagnosis of early-stage breast cancer received adjuvant chemotherapy. Their study implied that 71% of women in New Mexico who had this disease were undertreated during this period. The accompanying Editors' Notes state that “many unnecessary deaths could be prevented” if National Institutes of Health (NIH) guidelines are followed. We believe that the study conclusion and the editorial comment are both unwarranted.
The number of patients examined by Du and colleagues perplexes us. Although the authors reported that they screened records on 5101 patients, when we added the numbers of patients from whom information regarding chemotherapy was gleaned as reported in the Methods section, there seem to have been 5947 cases involved. An explanation of this discrepancy would be appreciated.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only